Dendritic Cell Cancer Vaccine Market COVID-19 Impact Analysis, by Product Type (CreaVax, Sipuleucel-T (Provenge), and Others) and by End User (Pediatrics and Adults), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Dendritic Cell Cancer Vaccine market size was valued at USD 539.42 Million in 2022, expanding at a CAGR of 12.22% from 2023 to 2030.
A dendritic cell cancer vaccine is a treatment method in which dendritic cells, a kind of immune cell, are used to activate the patient\'s immune system to target and eliminate cancer cells. Dendritic cells are loaded with cancer-specific antigens from either the patient\'s own tumor or synthetic sources before being reintroduced into the patient\'s body. This process stimulates the immune system, making it more capable of recognizing and attacking cancer cells. Dendritic cell cancer vaccines are being researched as a possible immunotherapy to treat many forms of cancer and boost the body\'s natural defenses against the illness.
Dendritic Cell Cancer Vaccine Market Dynamics
- The rise in the number of cancer patients to propel the market growth
Increased government support for the development of cancer vaccines, as well as breakthroughs in vaccination technology, are driving market expansion. Male cancer cases were anticipated to reach 15,585,096 by 2040, while female cancer cases were expected to reach 13,302,846 by 2040. The growing prevalence of cancer among the worldwide population is likely to fuel market expansion. Similarly, the European Cancer Information System reported in 2020 that the projected incidence of non-melanoma skin cancers in 2020 was 2,681,958 and was predicted to rise to 3,244,076 by 2040. The rising prevalence of cancer in various nations is likely to fuel demand for cancer vaccines, propelling market expansion over the next several years.
Dendritic Cell Cancer Vaccine Market- Key Insights
- As per the analysis shared by our research analyst, the Global Dendritic Cell Cancer Vaccine market is estimated to grow annually at a CAGR of around 12.22% over the forecast period (2023-2030)
- The Dendritic Cell Cancer Vaccine market is projected to grow at a significant rate due to the rise in the number of cancer patients to propel the market growth
- Based on Type segmentation, Sipuleucel-T (Provenge) was predicted to show maximum market share in the year 2022
- Based on End-User segmentation, Adults were the leading End-User in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Dendritic Cell Cancer Vaccine Market- Segmentation Analysis:
The Global Dendritic Cell Cancer Vaccine market is segmented on the basis of Type, End-User, and Region.
The market is divided into categories based on Type: By creaVax, sipuleucel-T (Provenge), and others. Sipuleucel-T\'s potential to successfully boost an individual\'s immunity against tumor cells is increasing its market demand. The vaccine was licensed by the US Food and Drug Administration in 2010 for the treatment of castrate-resistant prostate cancer. Many studies have found that utilizing Sipuleucel-T increases immunity, has few negative effects, and increases a survivor\'s longevity.
The market is divided into categories based on End-User: Pediatrics and Adults. Due to the increasing number of cancer cases throughout the world in 2022, the adult vaccinations market category had the largest market share. Additionally, a large number of researchers throughout the world are doing in-depth studies to generate efficient vaccination candidates to realize prospective treatment solutions.
Dendritic Cell Cancer Vaccine Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America region is expected to grow. In 2022, the market for dendritic cell cancer vaccines will be dominated by North America. An extraordinary increase in cancer cases and numerous research studies supported by university research institutes and pharmaceutical behemoths are mostly to blame for the region\'s dendritic cell cancer vaccine market expansion.
Dendritic Cell Cancer Vaccine Market- Competitive Landscape:
Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, technology, reputation, and availability. Some of the primary Types used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, in 2022, Medigene and BioNTech have agreed to work together to develop T-cell immunotherapies that target several solid tumor sites. Through the partnership, Medigene\'s preclinical T-cell receptors (TCR) initiatives, which employ Medigene\'s switch-receptor technology for the creation of TCR treatments and dendritic cell vaccines, will be acquired by BioNTech..
Recent Developments:
- In June 2020, In order to conduct research on cancer vaccines made from dendritic cells employing single-use culture containers from Saint-Gobain for clinical-scale, R&D, and commercial phase manufacturing of vaccines, Saint-Gobain Life Sciences joined forces with the RI-MUHC, Kanyr Pharma Inc., and McGill University.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DENDRITIC CELL CANCER VACCINE MARKET KEY PLAYERS
- Vaximm AG
- SOTIO
- Scancell Holdings PLC
- Northwest Biotherapeutics (Now known as Cognate BioServices)
- NewLink Genetics (Now known as Lumos Pharma)
- Medigene AG
- Immunicum
- Dendreon Pharmaceuticals LLC
- DCPrime
- DanDrit Biotech
- CIMAB S.A. (Cuba)
- Cellular Biomedicine Group
- Bellicum Pharmaceuticals
- Batavia Biosciences
- Argos Therapeutics (Now part of Roivant Sciences)
GLOBAL DENDRITIC CELL CANCER VACCINE MARKET, BY TYPE
- CreaVax
- Sipuleucel-T (Provenge)
- Others
GLOBAL DENDRITIC CELL CANCER VACCINE MARKET, BY END-USER
- Pediatrics
- Adults
GLOBAL DENDRITIC CELL CANCER VACCINE MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
Rest of MEA
TABLE OF CONTENT
1. Dendritic Cell Cancer Vaccine Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Dendritic Cell Cancer Vaccine Market Snippet by Type
2.1.2. Dendritic Cell Cancer Vaccine Market Snippet by End-User
2.1.3. Dendritic Cell Cancer Vaccine Market Snippet by Country
2.1.4. Dendritic Cell Cancer Vaccine Market Snippet by Region
2.2. Competitive Insights
3. Semiconductor Memory Key Market Trends
3.1. Dendritic Cell Cancer Vaccine Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Dendritic Cell Cancer Vaccine Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Dendritic Cell Cancer Vaccine Market Opportunities
3.4. Dendritic Cell Cancer Vaccine Market Future Trends
4. Semiconductor Memory Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Dendritic Cell Cancer Vaccine Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Dendritic Cell Cancer Vaccine Market Landscape
6.1. Dendritic Cell Cancer Vaccine Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Dendritic Cell Cancer Vaccine Market – By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
7.1.2. CreaVax
7.1.3. Sipuleucel-T (Provenge)
7.1.4. Others
8. Dendritic Cell Cancer Vaccine Market – By End-User
8.1. Overview
8.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
8.1.2. Pediatrics
8.1.3. Adults
9. Dendritic Cell Cancer Vaccine Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
9.2. North America
9.2.1. Overview
9.2.2. Semiconductor Memory Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.2.5. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Semiconductor Memory Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.5. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.7. Italy
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.7.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.7.4. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.8. United Kingdom
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.8.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.8.4. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.9. France
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.9.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.9.4. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.10. Russia
9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.10.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.10.3. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.11. Netherlands
9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.11.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.11.3. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.12. Sweden
9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.12.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.12.3. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.13. Poland
9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.13.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.13.3. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.14. Rest of Europe
9.3.14.1. Overview
9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.14.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.3.14.4. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Semiconductor Memory Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.6.4. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.7.4. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.8.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.8.4. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.9. South Korea
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.9.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.9.4. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.11. Thailand
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.11.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.11.4. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.12. Indonesia
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.12.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.12.4. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Semiconductor Memory Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Semiconductor Memory Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Semiconductor Memory Industry
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Vaximm AG
10.2.2. SOTIO
10.2.3. Scancell Holdings PLC
10.2.4. Northwest Biotherapeutics (Now known as Cognate BioServices)
10.2.5. NewLink Genetics (Now known as Lumos Pharma)
10.2.6. Medigene AG
10.2.7. Immunicum
10.2.8. Dendreon Pharmaceuticals LLC
10.2.9. DCPrime
10.2.10. DanDrit Biotech
10.2.11. CIMAB S.A. (Cuba)
10.2.12. Cellular Biomedicine Group
10.2.13. Bellicum Pharmaceuticals
10.2.14. Batavia Biosciences
10.2.15. Argos Therapeutics (Now part of Roivant Sciences)
11. 360 Degree Analyst View
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
